Host: |
Goat |
Applications: |
Pep-ELISA/IHC/IF/FC |
Reactivity: |
Human/Mouse/Rat/Dog/Cow |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-Histamine Receptor H1 (C-Term) is suitable for use in ELISA, Immunohistochemistry, Immunofluorescence and Flow Cytometry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
IHC-4-6µg/ml, 5µg/mlFC-Flow cytometric analysis of A431 cells. 10ug/mlELISA-antibody detection limit dilution 1:32000. |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
HRH1 |
Gene ID: |
3269 |
Uniprot ID: |
HRH1_HUMAN |
Immunogen Region: |
C-Term |
Accession Number: |
NP_000852.1; NP_001091681.1; NP_001091682.1; NP_001091683.1 |
Specificity: |
Variants (NP_000852.1; NP_001091681.1; NP_001091682.1; NP_001091683.1) encode the same protein. |
Immunogen Sequence: |
CNENFKKTFKRILH |
Function | In peripheral tissues, the H1 subclass of histamine receptors mediates the contraction of smooth muscles, increase in capillary permeability due to contraction of terminal venules, and catecholamine release from adrenal medulla, as well as mediating neurotransmission in the central nervous system. |
Protein Name | Histamine H1 ReceptorH1rHh1r |
Database Links | Reactome: R-HSA-390650Reactome: R-HSA-416476 |
Cellular Localisation | Cell MembraneMulti-Pass Membrane Protein |
Alternative Antibody Names | Anti-Histamine H1 Receptor antibodyAnti-H1r antibodyAnti-Hh1r antibodyAnti-HRH1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance